1. PHASE 1 STUDY OF ANTICD19 CAR‐T CELLS WITH TNFα TRANSMEMBRANE DOMAIN AND 41BB, CD3ζ COSTIMULATORY DOMAINS. RESPONSES IN SUBJECTS WITH RAPIDLY PROGRESSIVE LYMPHOMA. (12th June 2019) Authors: Caimi, P.F.; Reese‐Koc, J.S.; Otegbeye, F.; Schneider, D.; Chamoun, K.; Boughan, K.M.; Cooper, B.W.; Galloway, E.; Gallogly, M.M.; Kruger, W.; Worden, A.; Kadan, M.; Malek, E.; Metheny, L.; Tomlinson, B.; Wald, D.N.; Sekaly, R.P.; Orentas, R.; Dropulic, B.; de Lima, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAFETY AND EFFICACY OF VENETOCLAX COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (VICER) FOR TREATMENT OF RELAPSED DLBCL: FINAL RESULTS FROM THE PHASE 1TRIAL. (12th June 2019) Authors: Caimi, P.F.; Jagadeesh, D.; Boughan, K.; Dean, R.; Cooper, B.; Pohlman, B.; Gallogly, M.; Ondrejka, S.; Moore, E.; Oduro, K.; Hsi, E.D.; de Lima, M.; Hill, B.T. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗